Correlation Between DSV Panalpina and Zealand Pharma
Can any of the company-specific risk be diversified away by investing in both DSV Panalpina and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DSV Panalpina and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DSV Panalpina AS and Zealand Pharma AS, you can compare the effects of market volatilities on DSV Panalpina and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DSV Panalpina with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of DSV Panalpina and Zealand Pharma.
Diversification Opportunities for DSV Panalpina and Zealand Pharma
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between DSV and Zealand is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding DSV Panalpina AS and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and DSV Panalpina is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DSV Panalpina AS are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of DSV Panalpina i.e., DSV Panalpina and Zealand Pharma go up and down completely randomly.
Pair Corralation between DSV Panalpina and Zealand Pharma
Assuming the 90 days trading horizon DSV Panalpina is expected to generate 2.84 times less return on investment than Zealand Pharma. But when comparing it to its historical volatility, DSV Panalpina AS is 2.23 times less risky than Zealand Pharma. It trades about 0.08 of its potential returns per unit of risk. Zealand Pharma AS is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 29,120 in Zealand Pharma AS on September 1, 2024 and sell it today you would earn a total of 43,880 from holding Zealand Pharma AS or generate 150.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
DSV Panalpina AS vs. Zealand Pharma AS
Performance |
| Timeline |
| DSV Panalpina AS |
| Zealand Pharma AS |
DSV Panalpina and Zealand Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DSV Panalpina and Zealand Pharma
The main advantage of trading using opposite DSV Panalpina and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DSV Panalpina position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.The idea behind DSV Panalpina AS and Zealand Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Zealand Pharma vs. Bavarian Nordic | Zealand Pharma vs. Ambu AS | Zealand Pharma vs. Genmab AS | Zealand Pharma vs. ALK Abell AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets |